Blood and starch in cardiac surgery [8]

Chest

Volumn 125, Issue 6, 2004, Pages 2369-2370

  Shander, Aryeh ^a   Rijhwani, Tanuja ^a   Moskowitz, David ^a   Spence, Richard ^b  

^a ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^b St Agnes Healthcare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PROTAMINE; STARCH;

BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; COMORBIDITY; CORONARY ARTERY BYPASS SURGERY; DISEASE SEVERITY; HEMATOCRIT; HUMAN; LETTER; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; THORAX DRAINAGE;

EID: 2942711385     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.6.2369     Document Type: Letter

References (16)

1. Avorn J, Patel M, Levin R, et al. Hetastarch and bleeding complications after coronary surgery. Chest 2003; 124:1437-1442
2. Kasper SM, Meinert P, Kampe S, et al. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 2003; 99:42-47
3. Haisch G, Boldt J, Krebs C, et al. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 2001; 15:316-321
4. Gallandat Huet RC, Siemons AW, Baus D, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000; 47:1207-1215
5. Munsch CM, MacIntyre E, Machin SJ, et al. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. Br J Surg 1988; 75:675-678
6. Palanzo DA, Parr GV, Bull AP, et al. Hetastarch as a prime for cardiopulmonary bypass. Ann Thorac Surg 1982; 34:680-683
7. Sade RM, Stroud MR, Crawford FA Jr, et al. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985; 89:713-722
8. Kirklin JK, Lell WA, Kouchoukos NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg 1984; 37:40-46
9. Knutson JE, Deering JA, Hall FW, et al. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000; 90:801-807
10. Keyser EJ, Latter DA, Morin JE, et al. Pentastarch versus albumin in cardiopulmonary bypass prime: impact on blood loss. J Card Surg 1999; 14:279-286
11. Cope M, Jeffrey T, Banks B, et al. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg 1997; 63:78-82
12. Strauss R. Review of the effects of hydroxyethyl starch on the blood coagulation system. Transfusion 1981; 21:299-302
13. Wilkes NJ, Woolf RL, Powanda MC, et al. Hydroxyethyl starch in balanced electrolyte solution (Hextend): pharmacokinetic and pharmacodynamic profiles in healthy volunteers. Anesth Analg 2002; 94:538-544
14. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a metaanalysis of postoperative bleeding. Ann Thorac Surg 2001; 72:527-533
15. Goodnough L, Johnston M. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991; 265:86-90
16. Stover E, Siegel LC, Body SC, et al. Institutional variability in red blood cell conservation practices for coronary artery bypass graft surgery: Institutions of the MultiCenter Study of Perioperative Ischemia Research Group. J Cardiothorac Vasc Anesth 2000; 14:171-176